(Refiles to remove extra word in paragraph 4)
* Nikkei has shed 2.1 for week, dropped 1 pct for month so far
* Nikkei poised to post 5.8 pct gain for quarter
* Announcement of new era name could trigger festive mood – analyst
By Ayai Tomisawa
TOKYO, March 29 (Reuters) – Japan’s Nikkei rose on Friday on optimism about the latest round of U.S.-China trade talks, with cyclical sectors such as shipping and machinery advancing on the last day of the fiscal year.
Daiichi Sankyo Co was in focus, jumping 16 percent to a daily-limit high of 5,100 yen after the drugmaker and AstraZeneca Plc have signed a potential multibillion-dollar collaboration to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan.
The Nikkei share average